To describe recent advances in the understanding of virus-specific CD4 þ T cell dysfunction in chronic viral infections, with an emphasis on HIV disease. We highlight features that are distinctive for CD4 þ T cells, as opposed to their CD8 þ T cell counterparts.
INTRODUCTION

CD4
þ T cell responses play a critical role in the development of effective cellular and humoral antiviral immunity [1] . CD4 þ T cell depletion in murine models has firmly documented the crucial role of CD4 þ T cell help [2, 3] . Furthermore, adoptive transfer of lymphocytic choriomeningitis (LCMV)-specific CD4 þ T cells into mice with chronic LCMV infection restored the function of exhausted virusspecific CD8
þ T cells and reduced viral burden [4] . HIV infection is a prototypic example of the clinical relevance of CD4 þ T cells, setting the stage in understanding opportunistic infections and tumors associated with CD4 þ T cell loss. For example, a correlation was found between loss of CMV-specific CD4 þ T cell function and end-organ disease, and conversely, immune restoration and clinical improvement on antiviral therapy (ART) [5] . During HCV infection, a robust early CD4 þ T cell response has been associated with subsequent viral clearance, whereas weak T helper (Th) responses have been associated with subsequent development of chronic hepatitis C [6] . Multiple lines of evidence thus suggest that effective CD4 þ T cell responses will also be an important component of any effective therapeutic or prophylactic HIV vaccine. Although it is very difficult to discriminate causes and consequences of viral control for a specific immunological readout in humans in the absence of a specific intervention, studies in specific contexts have been informative in terms of characteristics of HIV-specific CD4 þ T cell impairment (e.g., investigation of elite controllers, who are patients able to spontaneously control virus in the absence of therapy [7, 8] , longitudinal studies from the time of acute infection and on or off ART, etc.). The significant progress made over the past few years in understanding mechanisms of CD4 þ T cell dysfunction in chronic infections sheds light on pathways that may need to be targeted to improve CD4 þ T cell help against HIV. Here, we highlight important differences in exhaustion mechanisms between the CD4 þ and CD8 þ T cell compartments, a knowledge that will likely be instrumental in assessing desirable features of CD4 þ T cell responses elicited by therapeutic interventions to reach functional HIV cure or prevent infection.
LEARNING FROM MECHANISMS OF CD8
R T CELL DYSFUNCTION Naïve T cell activation and differentiation is a tightly orchestrated process that depends on the characteristics of the interaction with the antigen-presenting cell, the duration of antigen encounter, the strength of T-cell receptor (TCR) signaling [9 && ] and the microenvironment. Alterations of these parameters can result in various states of T cell impairment, which include exhaustion (defined as a progressive loss of effector functions in the setting of antigen persistence), tolerance, anergy and senescence (reviewed in [10] ). Although distinction of these settings of impairment is useful and gives prominence to important differences in the differentiation programs of antigen-specific T cells [10, 11] , it appears that these distinctions are also blurred by shared cores of gene expression changes, whose underlying epigenetic basis in the setting of viral infections is subject to active investigation [12] . It is particularly relevant for humans as a long-lived species with very diverse environmental exposure as compared with murine laboratory models, and whose CD4 þ and CD8 þ T cell repertoires appear to be shaped by previous exposures to persistent and nonpersistent microorganisms, which in turn may impact on disease outcome [13 && ,14] . Although there are likely such interspecies differences, studies in the murine LCMV model have been instrumental in the major progress made over the past several years in the understanding of mechanisms of T cell exhaustion in both animal models and humans (reviewed in [15] ).
Studies in LCMV infection have led to identification of critical mediators of virus-specific CD8 þ T cell exhaustion, such as programmed-death 1 (PD-1), and allowed critical proof-of principle studies of partial reversibility of antiviral functions by in-vivo blockade (reviewed by Kuchroo et al. in this issue). Whereas initial work in infectious disease models lead the way, many of the mechanisms identified are shared with tumor-associated CD8 þ T cell exhaustion. It is actually in the oncology field that the major applications of these discoveries have been translated to clinical care thus far; blockade of the PD-1 pathway in several phase III trials yielded remarkable results in diverse type of metastatic cancers [16] [17] [18] [19] . The specific functions restored associated with positive outcome remain to be identified, and it is not clear whereas apart from CD8 þ tumorinfiltrating lymphocytes other cells types, including CD4 þ T cells, play a critical role in tumor control. Advances have been slower in immunotherapy of chronic infectious diseases in humans, this being in because of better disease prognosis with current treatment regimens as compared with metastatic cancer (reviewed in [20] ). During the exhaustion process, CD8 þ T cells appear to undergo a hierarchical loss of function that mirrors the accumulation of inhibitory coreceptors on the cell surface (Kuchroo et al. in this issue, and [21] ). Some of the critical transcriptional events determining these key features of the CD8 þ T cell exhaustion program have been discovered ( [22] [23] [24] [25] , reviewed by Kuchroo et al. and Collins and Henderson in this issue). These advances also provide potential candidate genes, robust comparative benchmarks and validated experimental approaches for studies of virus-specific CD4 þ T cell dysfunction in chronic infection.
KEY POINTS
CD4
þ T cell plays a key role in effective antiviral immune responses.
Mechanisms of CD4
þ T cell and CD8 þ T cell impairment differ in key aspects.
Recent studies of T helper (Th) cells have revealed more functional flexibility in cytokine production than predicted by earlier work, and this plasticity plays an important role in different pathogenesis models.
Virus-specific CD4
þ T cell dysfunction results from combination of an exhaustion program and skewing in Th lineage differentiation which impact function.
HIV-specific CD4
þ T cell function can be restored by manipulation of inhibitory molecules that mediate exhaustion, such as PD-1.
Whether immunotherapeutic strategies targeting CD4
þ T cell defects can complement ART to help achieve functional HIV cure needs to be determined.
SKEWED LINEAGE DIFFERENTIATION CONTRIBUTES TO CD4 R T CELL DYSFUNCTION IN CHRONIC VIRAL INFECTIONS
Compared with the CD8 þ T cells, less is known on the molecular determinants of virus-specific CD4 þ T cell dysfunction in chronic infections, including HIV. This slower progress reside in part in the overall lower frequencies of CD4 þ T cell responses compared with CD8 þ T cells in many infections, the breadth of the CD4 þ T cell repertoire, the shorter lifespan as HIV-specific CD4 þ T cells may be preferred targets of HIV compared with some other specificities [26] , the reduced availability of some important tools (for example, major histocompatibility complex (MHC) class II tetramers are much more challenging to manufacture than their MHC class I counterparts), and the indirect readouts of function -CD4 þ T cells act mostly by regulating functions of other immune cell subsets. A cardinal feature of CD4 þ T cells is their capacity to differentiate into functional subsets that express different sets of cytokines, cosignaling molecules and homing receptors, which ensure their ability to provide help to diverse immune cell populations in different body compartments [27] . Early work showing that cytokine production by CD4 þ T cells was not stochastic led to definition of CD4 þ T cell subsets as distinct lineages [T helper 1, T helper 2, and subsequently T helper 17, T follicular helper (Tfh), Tregs, etc.]. Whereas this conceptual framework was useful to identify molecular mechanisms that determine CD4
þ T cell differentiation, in particular 'master transcription factors', it imperfectly reflected in-vivo dynamics of CD4 þ Th cell responses in infections, autoimmune diseases and other pathological conditions. Newer data support of much more plastic behavior of CD4 þ T cell responses, which is in particular impacted by the inflammatory environment [a T helper 17 cell, for example can easily become an interferon (IFN)-g producer [28] CD4 þ T cells can change their profile of cytokine production and frequently acquired a 'mixed' phenotype relative to classically defined lineages (reviewed in [29, 30] ). There are many circumstances in which the expression of master regulators is transient or in which cells express more than one master regulator. Their role has thus more to be understood as a network, rather than unique determinants [31] [32] [33] . CD4 þ T cell plasticity also plays an important role in chronic viral infections and adds complexity to the understanding of T helper cell impairment to persistent pathogens. It is important to note that some models of viral infection have shown both loss and gain of specific CD4 þ T cell functions. Like CD8 þ T cells, virus-specific CD4 þ T cells in chronic infection tend to become 'antigen-addicted' and undergo attrition when not exposed to the pathogen. Also similar to CD8 þ T cells, LCMVspecific CD4 þ T cells in chronic LCMV clone 13 infection show decreased ability to proliferate and secrete interleukin-2 and tumor necrosis factor-a, whereas production of IFN-g is comparatively better preserved [34] . However, other functions such as interleukin-10 production [35, 36] and interleukin-21 secretion [37, 38] are increased as compared with infection with the acute LCMV Armstrong strain. Interleukin-21 is an important cytokine for both CD8 þ T cells and B cells and data suggest that at least part of the Tfh-mediated help for humoral responses is maintained. It is important to note that in the absence of CD4 depletion, LCMV clone 13, which is frequently used as a prototypic chronic infection model in mice, is ultimately controlled in the periphery after 60-80 days [2, 3] . In this setting, Th cell development is geared by chronic antigen stimulation away from T helper1 polarization toward a Tfh-like phenotype, which contributes to the delayed viral control [39] . This illustrates the potential advantages of CD4 þ T cell plasticity in redirecting development toward a lineage beneficial to the host. LCMV clone 13 infection mimicks in some aspects the dynamics observed in human HIV controllers and HCV resolvers in whom control of viral replication is frequently only achieved several weeks after acute infection. The fact that HIVspecific CD4 þ T cells from elite controllers are able to produce significantly more interleukin-21 than those of progressors [40] can be relevant in this regard. How dependent -and thus potentially reversible -is CD4 þ T cell lineage skewing dependent on external cues, including repetitive TCR stimulation and the inflammatory environment? Adoptive transfer experiments suggest that CD4 þ T cell might be more plastic than their CD8 þ T cell counterparts [41] .
These findings are at least in part mirrored in major chronic viral infections in humans. CD4 þ T cell proliferative capacity to HIV [42] and HCV [43] is lost in chronic infection, and associated by reduced 'polyfunctionality', that is, the capacity of individual cells to produce multiple cytokines, in particular a reduced ability to produce interleukin-2 [44] [45] [46] . In contrast to CD8 þ T cells [47] , control of viral load by ART significantly restores proliferation and interleukin-2 secretion by HIVspecific CD4 þ T cells [48] , suggesting that at least part of the differences in HIV-specific CD4 þ T cell features noted between elite controllers and progressors is a consequence, rather than a cause, of viral control. Data in HIV and HCV infections also suggest some skewing of lineage differentiation consistent with animal models. These viruses frequently elicit large quantities of CD4 þ T cell-dependent virus-specific antibodies that in some cases can even cause immunopathology (e.g., HCV-related vasculitis due to deposition of immune complexes [49] 
CD4 R T CELL EXHAUSTION AS A DISTINCT CELL FATE PROGRAM
The alterations of CD4 Th cells that include not only mere loss of functions but also -at least in some infectious disease contexts -skewing toward new or mixed lineage subset properties raise the question as to whether CD4 þ T cells are also subjected to a real cell-intrinsic exhaustion program. Studies initiated in HIV infection have been quite informative in this regard and support the concept of CD4 þ T cell exhaustion. Shortly after that the role of the PD-1 pathway was demonstrated for HIV-specific CD8 þ T cells, its implication in HIV-specific CD4
þ T cell impairment was demonstrated in in-vitro experiments. The PD-1 molecule is upregulated on virusspecific CD4 þ T cells [54] [55] [56] and its expression was correlated with markers of HIV disease progression, positively with viral load and negatively with CD4 count. Blockade of the PD-1 pathway in vitro using blocking antibodies restored proliferation and cytokine secretion by HIV-specific CD4 þ T cells [55] [56] [57] . PD-1 expression appears to vary according to anatomic sites, with higher levels observed in lymph nodes compared with peripheral blood [55] . Although ART reduces PD-1 expression levels on HIV-specific T cells, it does not abrogate it completely. Consistent with this observation, blockade of the PD-1 pathway was found to be effective at restoring CD4 þ T cell cytokine production in vitro in ART-treated subjects, although to a lesser extent than in subjects with ongoing viral replication [56] . Such observations are made possible by the development of finer in-vitro assays to assess the impact that different mediators of dysfunction have on the cytokine secretion profile of Th cells [58] . These results suggest a potential role of immunotherapeutic interventions targeting this pathway as an adjuvant to ART. More recently, PD-1 was shown to regulate function of Tfh cells and blockade of the PD-1 pathway restored HIV-specific Tfh help to B cells resulting in enhanced HIV-specific immunoglobulin production in vitro [51 && ]. Apart from PD-1, other inhibitory coreceptors have been identified as contributing to HIV-specific CD4 þ T cell impairment. Another member of the B7:CD28 family, cytotoxic T-lymphocyte antigen 4 (CTLA-4), was also shown to play a critical role in CD4 þ T cell dysfunction. Similar to PD-1, CTLA-4 is upregulated on HIV-specific CD4 þ T cells and mediated a reversible T cell dysfunction [54, 59] . However, in contrast to PD-1 that regulates both CD4 þ and CD8
þ T cell responses, CTLA-4 overexpression and functional impact are largely specific restricted to HIV-specific CD4 þ T cells. Further studies demonstrated that coexpression of PD-1, CTLA-4 and another coinhibitory receptor, T cell immunoglobulin (Tim-3), was associated with a more exhausted HIV-specific CD4 þ T cell phenotype [60] . These findings are further supported by a recent study in the LCMV mouse model which demonstrated that the percentage of virus-specific CD4 þ T cells decreased as the number of coexpressed inhibitory ligands increased [61] . Further investigations confirmed major differences in the sets of inhibitory coreceptors modulating HIV-specific CD4 þ and CD8 þ T cell responses (summarized in Fig. 1 ): in contrast to HIV-specific CD8 þ T cells, CD4 þ T responses do not express significant levels of the inhibitory molecules CD244 (2B4) and CD160 [56] . Blockade of coinhibitory receptors on HIV-specific CD4 þ T cells can have robust additive effects with blockade of cell-extrinsic pathways associated with CD4 þ T cell impairment. One such pathway is interleukin-10, which has been shown in several studies to be upregulated in HIV infection and able to inhibit CD4 þ T cell function [62, 63] . When compared with PD-1 blockade, interleukin-10 blockade appears to preferentially restore IFN-g secretion as compared with other cytokines, consistent with its known role as inhibitor of T helper1 responses. þ T cells compared with acute resolving infection, there was a loss of a strong T helper1-associated signature in chronic disease without obvious skewing toward canonical Th cell lineages, although several Tfh-associated genes were upregulated. This study thus provides a reference framework to investigate further mechanisms of CD4 þ T cell exhaustion and interventions to restore functions.
CONCLUSION -CD4
R T CELL DYSFUNCTION: NOT A COPYCAT OF CD8 R T CELL IMPAIRMENT Whereas CD8 þ T dysfunction in chronic viral diseases is strongly linked to a distinct exhaustion program, alterations of pathogen-specific CD4 þ T cell functions result from a broader combination of skewed lineage differentiation and of an exhaustion program characterized by features common to the two T cell subsets and by factors unique to Th cell cells. These two categories of mechanisms are present in HIV infection, along with CD4 þ T cell depletion in the case of progressive disease. Furthermore, recent work in different pathogenesis models, in particular in autoimmune diseases, has exemplified a previously unappreciated degree of functional plasticity of CD4 þ T cells in inflammatory environments, which can have significant implications for HIV infection. Therefore, interventions to elicit or restore effective HIV-specific CD4 þ T cells need to be tailored to the specificities of this immune cell subset and may differ from those focusing on CD8 þ T cells. Further investigations are needed to investigate underlying mechanisms of CD4 þ T cell dysfunction in chronic viral infections in humans, which may differ significantly depending on the offending pathogen. þ T cell responses allows identification of both shared and unique modules of gene associated with exhaustion of the CD4 þ and/ or CD8 þ T cell populations.
